Male chain smokers looking to kick the habit once and for all could benefit from combining two cessation treatments, says new research from Duke Medicine.
More than 60 percent of men who were “highly dependent” on nicotine were able to successfully quit smoking using a combination of varenicline and bupropion compared to just 14 percent who took only varenicline, said Jed Rose, the study’s lead author, in a release. Rose serves as director of the Duke Center for Smoking Cessation.
The two…
